NASDAQ · Drug Manufacturers - General · USD
Medicus Pharma Ltd. (MDCX) Stock Analysis
Medicus Pharma Ltd. (MDCX) is a Drug Manufacturers - General stock listed on NASDAQ and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
MDCX Key Statistics
As of Sep 4, 2026Trading
- Open
- $0.16
- Previous Close
- $0.17
- Day's Range
- 0.16–0.18
- 52-Week Range
- 0.15–3.05
- Volume
- 15.17M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- −0.48
Valuation
- Market Cap
- $10.87M
- P/E Ratio
- unprofitable
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −2.36
Financials (FY)
- Revenue (FY)
- $0.00
- Net Income (FY)
- −$35.44M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 0.00%
- Shares Outstanding
- 63.18M
- 1-Year Return
- −90.60%
Dividend and dates
- Avg Volume
- 3.08M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
MDCX Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −88.76% |
| 2025 | −37.04% |
| 2024 (partial year) | −8.30% |
As of September 4, 2026.
MDCX Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $0.00 | −$35.44M | — |
| 2024 | $0.00 | −$11.16M | — |
| 2023 | $0.00 | −$5.31M | — |
| 2022 | $0.00 | −$1.69M | — |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $0.00 | — | −$34.36M | −$35.44M | — |
| 2024 | $0.00 | — | −$11.18M | −$11.16M | — |
| 2023 | $0.00 | — | −$2.66M | −$5.31M | — |
| 2022 | $0.00 | — | −$978.42K | −$1.69M | — |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
MDCX Valuation vs Drug Manufacturers - General Median
Median of 21 stocks| Metric | MDCX | Drug Manufacturers - General median | vs median |
|---|---|---|---|
| Profit margin | 0.00% | 8.09% | 8.1 pts below |
Medians across 21 Drug Manufacturers - General stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Medicus Pharma Inks Global Licensing Deal with Pfizer Worth Over $1 Billion
BenzingaMedicus Pharma Announces Co-Development And License Agreement With Pfizer For CD228-Targeting ADC PF-08046031, Paying $12M Upfront And $15M In One Year; Pfizer Eligible For Over $1B In Milestones Plus Royalties
BenzingaMedicus Pharma advances pipeline during Q2 with key milestones
YahooMedicus Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
YahooMedicus Pharma Q2 EPS $(0.21) Misses $(0.13) Estimate
BenzingaEXCLUSIVE: Medicus Pharma Launches Genomics-Guided Endometriosis Study In Abu Dhabi
Benzinga
All 8 articles ↓Show fewer ↑
Medicus Pharma Receives FDA's Study May Proceed Letter Authorization For Its Investigational New Drug For SKNJCT-005 To Start Phase 2b Clinical Study To Treat Gorlin Syndrome
BenzingaMedicus Pharma Announces Positive FDA Feedback For Its Optimized Phase 2 Clinical Trial Of Teverelix In Men Following A First Episode Of Acute Urinary Retention
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Drug Manufacturers - General Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
NVSNovartis AG
$304.10B
AZNAstraZeneca PLC
$252.33B
Popular Healthcare Stocks
UnitedHealth Group Incorporated
$356.47B
AMGNAmgen Inc.
$236.38B
TMOThermo Fisher Scientific Inc.
$226.94B
NVONovo Nordisk A/S
$206.02B
ABTAbbott Laboratories
$187.45B